Pharma Capital
Showing 6 of 6
Name Market Market Cap Share Price Daily Share Movement
m_pharma_5739c0416b400.png M Pharmaceutical CSE £3.19m £0.03 0.00% ico_glass.png
neph.png NephroGenex NASDAQ £- £- - ico_glass.png
vaxil.png Vaxil TSX-V £2.70m £0.06 0.00% ico_glass.png
ventripoint.png VentriPoint Diagnostics TSX-V £5.84m £0.22 -3.85% ico_glass.png
volition-logo.png VolitionRx NYSE £- £- - ico_glass.png
zynerba-pharmaceuticals.png Zynerba Pharmaceuticals NASDAQ £- £- - ico_glass.png

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.